These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 15982497

  • 1. Complementary roles of simple variables, NYHA and N-BNP, in indicating aerobic capacity and severity of heart failure.
    Williams SG, Ng LL, O'Brien RJ, Taylor S, Wright DJ, Li YF, Tan LB.
    Int J Cardiol; 2005 Jul 10; 102(2):279-86. PubMed ID: 15982497
    [Abstract] [Full Text] [Related]

  • 2. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV.
    J Heart Lung Transplant; 2007 May 10; 26(5):516-21. PubMed ID: 17449423
    [Abstract] [Full Text] [Related]

  • 3. Inverse Association Between Myocardial B-Type Natriuretic Peptide Release and Functional Capacity in Healthy Humans.
    Maeder MT, Thompson BR, Kaye DM.
    Heart Lung Circ; 2018 Aug 10; 27(8):995-1003. PubMed ID: 28969979
    [Abstract] [Full Text] [Related]

  • 4. Augmented response in plasma brain natriuretic peptide to dynamic exercise in patients with left ventricular dysfunction and congestive heart failure.
    Kato M, Kinugawa T, Ogino K, Endo A, Osaki S, Igawa O, Hisatome I, Shigemasa C.
    J Intern Med; 2000 Oct 10; 248(4):309-15. PubMed ID: 11086641
    [Abstract] [Full Text] [Related]

  • 5. Right heart dysfunction assessed with echography, B-type natriuretic peptide and cardiopulmonary test in patients with chronic heart failure.
    Troisi F, Greco S, Brunetti ND, Di Biase M.
    J Cardiovasc Med (Hagerstown); 2008 Jul 10; 9(7):672-6. PubMed ID: 18545065
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
    Kinugawa T, Kato M, Ogino K, Osaki S, Igawa O, Hisatome I, Shigemasa C.
    J Card Fail; 2003 Aug 10; 9(4):318-24. PubMed ID: 13680553
    [Abstract] [Full Text] [Related]

  • 10. B-type natriuretic peptide kinetics and cardiopulmonary exercise testing in heart failure.
    Maeder M, Wolber T, Rickli H, Myers J, Hack D, Riesen W, Weilenmann D, Ammann P.
    Int J Cardiol; 2007 Sep 03; 120(3):391-8. PubMed ID: 17182129
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R, Pousset F, Chafirovskaïa O, Carayon A, Hulot JS, Thomas D, Komajda M.
    Am Heart J; 2003 Oct 03; 146(4):729-35. PubMed ID: 14564330
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Usefulness of N-terminal pro-B-type natriuretic peptide levels to predict exercise capacity in hypertrophic cardiomyopathy.
    Thaman R, Esteban MT, Barnes S, Gimeno JR, Mist B, Murphy R, Collinson PO, McKenna WJ, Elliott PM.
    Am J Cardiol; 2006 Aug 15; 98(4):515-9. PubMed ID: 16893708
    [Abstract] [Full Text] [Related]

  • 15. Explanation of the variance in quality of life and activity capacity of patients with heart failure by laboratory data.
    Athanasopoulos LV, Dritsas A, Doll HA, Cokkinos DV.
    Eur J Cardiovasc Prev Rehabil; 2010 Aug 15; 17(4):375-9. PubMed ID: 19940776
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chronotropic and neurohumoral markers for the evaluation of functional capacity in patients with impaired left ventricular function.
    Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV.
    Hellenic J Cardiol; 2008 Aug 15; 49(1):26-32. PubMed ID: 18350779
    [Abstract] [Full Text] [Related]

  • 18. Rapid bedside measurement of brain natriuretic peptide in patients with chronic heart failure.
    Tjeerdsma G, de Boer RA, Boomsma F, van den Berg MP, Pinto YM, van Veldhuisen DJ.
    Int J Cardiol; 2002 Dec 15; 86(2-3):143-9; discussion 149-52. PubMed ID: 12419550
    [Abstract] [Full Text] [Related]

  • 19. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure.
    Lee SC, Stevens TL, Sandberg SM, Heublein DM, Nelson SM, Jougasaki M, Redfield MM, Burnett JC.
    J Card Fail; 2002 Jun 15; 8(3):149-54. PubMed ID: 12140807
    [Abstract] [Full Text] [Related]

  • 20. Utility of plasma N-terminal brain natriuretic peptide as a marker of functional capacity in patients with chronic severe mitral regurgitation.
    Yusoff R, Clayton N, Keevil B, Morris J, Ray S.
    Am J Cardiol; 2006 May 15; 97(10):1498-501. PubMed ID: 16679092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.